These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22,061 years of HHT patient life. Easey AJ; Wallace GM; Hughes JM; Jackson JE; Taylor WJ; Shovlin CL J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):743-8. PubMed ID: 12754343 [TBL] [Abstract][Full Text] [Related]
23. Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day-60 years. Krings T; Ozanne A; Chng SM; Alvarez H; Rodesch G; Lasjaunias PL Neuroradiology; 2005 Oct; 47(10):711-20. PubMed ID: 16136265 [TBL] [Abstract][Full Text] [Related]
24. [Genetic diagnostics of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)]. Major T; Gindele R; Szabó Z; Jóni N; Kis Z; Bora L; Bárdossy P; Rácz T; Karosi T; Bereczky Z Orv Hetil; 2019 May; 160(18):710-719. PubMed ID: 31030535 [TBL] [Abstract][Full Text] [Related]
25. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. Berg J; Porteous M; Reinhardt D; Gallione C; Holloway S; Umasunthar T; Lux A; McKinnon W; Marchuk D; Guttmacher A J Med Genet; 2003 Aug; 40(8):585-90. PubMed ID: 12920067 [TBL] [Abstract][Full Text] [Related]
27. Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2. Giordano P; Francavilla M; Buonamico P; Suppressa P; Lastella P; Sangerardi M; Miniello VL; Scardapane A; Lenato GM; Sabbà C Vasa; 2017 May; 46(3):195-202. PubMed ID: 28248153 [TBL] [Abstract][Full Text] [Related]
28. Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index. Singh S; Swanson KL; Hathcock MA; Kremers WK; Pallanch JF; Krowka MJ; Kamath PS J Hepatol; 2014 Jul; 61(1):124-31. PubMed ID: 24607625 [TBL] [Abstract][Full Text] [Related]
29. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital. Karlsson T; Cherif H Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589 [TBL] [Abstract][Full Text] [Related]
30. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. Abdalla SA; Geisthoff UW; Bonneau D; Plauchu H; McDonald J; Kennedy S; Faughnan ME; Letarte M J Med Genet; 2003 Jul; 40(7):494-502. PubMed ID: 12843319 [TBL] [Abstract][Full Text] [Related]
31. Pulmonary gas exchange in hereditary hemorrhagic telangiectasia patients with liver arteriovenous malformations. de Picciotto C; El Hajjam M; Karam C; Chinet T; Bonay M Respir Res; 2019 Jul; 20(1):137. PubMed ID: 31272464 [TBL] [Abstract][Full Text] [Related]
32. Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy. Suppressa P; Pagella F; Lenato GM; Gaetani E; Serio I; Masala MS; Spinozzi G; Lizzio R; Matti E; De Silvestri A; Passali GC; Aguglia M; Crocione C; Sabbà C Orphanet J Rare Dis; 2021 Sep; 16(1):378. PubMed ID: 34496900 [TBL] [Abstract][Full Text] [Related]